Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - NET CHANGE IN CASH
Net Change in Cash KROS - Keros Therapeutics, Inc.
52 M
LAST VALUE
87.12%
2 YEAR CAGR
23.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR